1. Kriplani Alka
2. Dash Biswa Bhusan

9789350251492

10.5005/jp/books/11624_13

1/e

2011

12

1. All India Institute of Medical Sciences, New Delhi, India, All India Institute of Medical Sciences, New Delhi, India; Menstrual Disorders Committee, FIGO, WHO-CCR, HRRC and Family Planning, All India Institute of Medical Sciences, New Delhi, India, All India Institute of Medical Sciences, New Delhi, India; FOGSI 2016, Human Reproduction Research Center and Family Planning, All India Institute of Medical Sciences, New Delhi, India, All India Institute of Medical Sciences, New Delhi, India; WHO HRRC and Family Planning, New Delhi, New Delhi, India, All India Institute of Medical Sciences (AIIMS), New Delhi, India, All India Institute of Medical Sciences, Fortis La Femme and Adiva Women Care, New Delhi, India, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, AIIMS, Delhi, AIIMS, New Delhi, India, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, All India Institute of Medical Sciences, New Delhi, krip
2. AIIMS, Ansari Nagar, Delhi, bishu_lee@yahoo.co.in, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India, All India Institute of Medical Sciences Ansari Nagar, New Delhi, India, Fortis La Femme Hospital, Adiva Women Care, New Delhi, India

Toxoplasma, immunosuppressive therapy, non-immune hydrops, mother to fetus transmission, congenital toxoplasmosis, chorioretinitis, antitoxoplasmic treatment, ultrasonography, cordocentesis, amniocentesis, chorionic villus sampling, seroconversion sulphonamides, pyrimethamine, spiramycin